The Indian Health Service awarded a purchase order to iCAD, Inc. for iCAD AI Mammography Software Licenses valued at $61,885.35 on June 1, 2026, under a sole source procurement. The order covers a base year plus four optional one-year renewal periods, with an ultimate completion date of May 31, 2031. Performance occurs in Nashua, New Hampshire. The purchase order funds renewal and continuation of iCAD 2D/3D Detection Per Exam Licenses for Fort Belknap Hospital's 3D Mammography Digital Breast Tomosynthesis suite, providing AI-assisted diagnostic support to radiologists. IHS determined iCAD as sole source based on proprietary ownership of the FDA-cleared deep-learning algorithm and exclusive licensing rights to provide mandatory software upgrades and support. The procurement originated from Notice of Intent to Award HHS-OMAS-26-1519994, posted April 2, 2026.